Daiwa Securities Adjusts Price Target on Intuitive Surgical to $460 From $430
Jefferies Adjusts SMC's Price Target to 80,300 Yen From 88,600 Yen, Keeps at Hold
Cognex Price Target Announced at $58.00/Share by Vertical Research
Cognex Analyst Ratings
Intuitive Surgical Analyst Ratings
Vertical Research Initiates Cognex at Buy With $58 Price Target
Truist Financial Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
Barclays Adjusts Price Target on Intuitive Surgical to $510 From $490
Nvidia Price Target Raised to $140.00/Share From $120.00 by Piper Sandler
NVIDIA Analyst Ratings
Analysts' Top Healthcare Picks: 4D Molecular Therapeutics (FDMT), Intuitive Surgical (ISRG)
Outperform Rating Reaffirmed for Intuitive Surgical on Strong Q2 2024 Performance and Da Vinci 5 Launch Success
BMO Capital Cuts Price Target on Dynatrace to $49 From $54, Maintains Outperform Rating
Dynatrace Analyst Ratings
Baird Maintains Outperform on Intuitive Surgical, Raises Price Target to $503
Piper Sandler Remains a Buy on Intuitive Surgical (ISRG)
Morgan Stanley Adjusts Price Target on Intuitive Surgical to $475 From $460, Maintains Equalweight Rating
Analysts' Top Healthcare Picks: Intuitive Surgical (ISRG), Nuvation Bio (NUVB)
Strong Performance and Growth Prospects Underpin Buy Rating for Intuitive Surgical
Intuitive Surgical Analyst Ratings